XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
6 Months Ended
Sep. 30, 2022
Stock-Based Compensation Recognized

The following table summarizes stock-based compensation expense by financial statement line item in the Company’s condensed consolidated statements of operations for each of the three and six months ended September 30, 2022 and 2021:

 

 

 

For the Three Months Ended September 30,

 

 

For the Six Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

 

 

 

 

 

 

Cost of revenue

 

$

1,358

 

 

$

1,300

 

 

$

2,754

 

 

$

2,330

 

Research and development

 

 

2,976

 

 

 

2,294

 

 

 

5,774

 

 

 

4,403

 

Selling, general and administrative

 

 

11,680

 

 

 

12,155

 

 

 

20,848

 

 

 

21,624

 

 

 

$

16,014

 

 

$

15,749

 

 

$

29,376

 

 

$

28,357

 

Summary of Stock Option Activity

The following table summarizes the stock option activity for the six months ended September 30, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Options

 

 

Exercise

 

 

Contractual

 

 

Value

 

 

 

(in thousands)

 

 

Price

 

 

Term (years)

 

 

(in thousands)

 

Outstanding at beginning of period

 

 

595

 

 

$

178.54

 

 

 

5.55

 

 

 

 

Granted

 

 

5

 

 

 

267.96

 

 

 

 

 

 

 

Exercised

 

 

(21

)

 

 

93.07

 

 

 

 

 

 

 

Cancelled and expired

 

 

(3

)

 

 

285.00

 

 

 

 

 

 

 

Outstanding at end of period

 

 

576

 

 

$

182.01

 

 

 

5.14

 

 

$

49,789

 

Exercisable at end of period

 

 

500

 

 

$

169.15

 

 

 

4.64

 

 

$

49,167

 

Options vested and expected to vest at end of period

 

 

576

 

 

$

182.01

 

 

 

5.14

 

 

$

49,789

 

 

Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted The weighted average grant-date fair values and weighted average assumptions used in the calculation of fair value of options granted were as follows:

 

 

 

For the Three Months Ended September 30,

 

 

For the Six Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Weighted average grant-date fair value

 

$

118.40

 

 

$

115.99

 

 

$

119.74

 

 

$

103.48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Valuation assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

Risk-free interest rate

 

 

3.32

%

 

 

0.77

%

 

 

3.20

%

 

 

0.79

%

Expected option life (years)

 

 

5.60

 

 

 

4.14

 

 

 

5.58

 

 

 

4.20

 

Expected volatility

 

 

43.49

%

 

 

44.72

%

 

 

43.50

%

 

 

44.30

%

Restricted Stock Units  
Summary of Restricted Stock Units Activity

The following table summarizes activity of restricted stock units for the six months ended September 30, 2022:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

 

 

(in thousands)

 

 

(per share)

 

Restricted stock units at beginning of period

 

 

307

 

 

$

274.32

 

Granted (1)

 

 

267

 

 

 

266.68

 

Vested

 

 

(122

)

 

 

284.98

 

Forfeited

 

 

(7

)

 

 

275.21

 

Restricted stock units at end of period

 

 

445

 

 

$

266.72

 

 

(1) Includes 19,000 performance-based awards granted due to greater than 100% target vesting.

Summary of Assumptions Used To Value Awards And Estimated Grant-Date Fair Value

The table below sets forth the assumptions used to value the outstanding market-based restricted stock units and the estimated grant-date fair value:

 

 

 

May 2021

 

 

May 2020

 

Risk-free interest rate

 

 

0.3

%

 

 

0.2

%

Expected volatility

 

 

44.8

%

 

 

35.5

%

Dividend yield

 

 

 

 

 

 

Remaining performance period (years)

 

2.8

 

 

 

2.9

 

Estimated fair value per share

 

$

292.40

 

 

$

349.28

 

Target performance (number of shares)

 

 

25,172

 

 

 

15,425